bromodeoxyuridine has been researched along with Parkinsonian Disorders in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (76.47) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ermine, CM; Frausin, S; Kauhausen, JA; Parish, CL; Stanic, D; Thompson, LH; Wright, JL | 1 |
| Amato, D; Anderson, S; Ben Abdallah, N; Deusser, J; Kohl, Z; Masliah, E; Müller, CP; Nuber, S; Riess, O; Tischer, L; Vogelgsang, J; Winkler, J | 1 |
| Ballerini, P; Bau, C; Caciagli, F; Ciccarelli, R; D'Alimonte, I; Elfeki, N; Gabriele, J; Jiang, S; Su, C | 1 |
| Baba, T; Date, I; Kadota, T; Kondo, A; Miyoshi, Y; Morimoto, T; Shingo, T; Tajiri, N; Tokunaga, K; Wang, F; Yasuhara, T; Yuan, WJ | 1 |
| Aigner, L; Aigner, R; Buerger, E; Desplats, P; Hagl, C; Karl, A; Klucken, J; Laemke, J; Masliah, E; Ploetz, S; Winkler, J; Winner, B | 1 |
| Altiraihi, T; Fathi, F; Movahedin, M; Mowla, SJ | 1 |
| Cenci, MA; Francardo, V; Konradi, C; Lees, AJ; Lindgren, HS; Luksik, AS; O'Sullivan, SS; Ohlin, KE; Sillivan, SE; Vassoler, FM | 1 |
| Dziewczapolski, G; Gage, FH; Kaspar, BK; Lie, DC; Shults, CW; Willhoite, AR | 1 |
| Burke, RE; El-Khodor, BF; Kholodilov, N; Oo, TF | 1 |
| Brundin, P; Frielingsdorf, H; Mohapel, P; Schwarz, K | 1 |
| Cooper, O; Isacson, O | 1 |
| Cai, Q; Gao, EJ; Ji, M; Liu, BF; Lu, Q; Xu, QY; Yang, H; Zeng, XZ | 1 |
| Brundin, P; Cenci, MA; Gardi, J; Lindgren, HS; Mohapel, P; Nyengaard, JR; Westin, JE | 1 |
| Hayakawa, H; Hayashita-Kinoh, H; Mizuno, Y; Mochizuki, H; Nihira, T; Seki, T | 1 |
| Agrawal, AK; Chaturvedi, RK; Seth, K; Shukla, S | 1 |
| Belzunegui, S; Garrido-Gil, P; Izal-Azcárate, A; López, B; Luquin, MR; Marcilla, I; San Sebastián, W; Vázquez-Claverie, M | 1 |
| Chen, J; Chopp, M; Li, Y; Lu, M; Wang, L; Zhang, L | 1 |
17 other study(ies) available for bromodeoxyuridine and Parkinsonian Disorders
| Article | Year |
|---|---|
Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis.
Topics: Adrenergic Neurons; Animals; Brain; Bromodeoxyuridine; Cell Death; Dopamine; Dopamine beta-Hydroxylase; Dopaminergic Neurons; Female; Ki-67 Antigen; Nerve Degeneration; Neural Stem Cells; Neurogenesis; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Saporins | 2018 |
Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Blotting, Western; Bromodeoxyuridine; Cell Count; Dopamine; Dorsal Raphe Nucleus; Doublecortin Domain Proteins; Exploratory Behavior; Feeding Behavior; Fluorescent Antibody Technique; Hippocampus; Humans; Male; Microscopy, Electron; Microtubule-Associated Proteins; Neurogenesis; Neurons; Neuropeptides; Parkinsonian Disorders; Rats, Transgenic; Serotonin; Synapses | 2016 |
Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Dopamine; Fibroblast Growth Factor 2; Guanosine; Intermediate Filament Proteins; Male; Motor Activity; Nerve Tissue Proteins; Nestin; Neurogenesis; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2009 |
Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis.
Topics: Animals; Behavior, Animal; Brain; Bromodeoxyuridine; Disease Models, Animal; Dopamine; Erythropoietin; Female; Neural Cell Adhesion Molecules; Neurogenesis; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Sialic Acids; Stilbamidines; Tyrosine 3-Monooxygenase | 2009 |
Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model.
Topics: Animals; Benzothiazoles; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dopamine Agonists; ErbB Receptors; Exploratory Behavior; Eye Proteins; Functional Laterality; Gene Expression Regulation; Homeodomain Proteins; Lateral Ventricles; Male; Neurogenesis; Neurons; Olfactory Bulb; Oxidopamine; Paired Box Transcription Factors; Parkinsonian Disorders; PAX6 Transcription Factor; Phosphopyruvate Hydratase; Pramipexole; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Receptors, Dopamine D3; Repressor Proteins; RNA, Messenger | 2009 |
Transplantation of retinoic acid treated murine embryonic stem cells & behavioural deficit in Parkinsonian rats.
Topics: Animals; Behavior, Animal; Bromodeoxyuridine; Embryonic Stem Cells; Female; Mice; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation | 2010 |
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Animals; Antigens, CD; Antigens, Surface; Antiparkinson Agents; Astrocytes; Behavior, Animal; Benserazide; Blood Vessels; Blood-Brain Barrier; Brain; Bromodeoxyuridine; Cell Count; Cells, Cultured; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Embryo, Mammalian; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Laminin; Levodopa; Male; Neovascularization, Pathologic; Nerve Tissue Proteins; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Up-Regulation; Vascular Endothelial Growth Factor A | 2011 |
The adult substantia nigra contains progenitor cells with neurogenic potential.
Topics: Animals; Antigens, Differentiation; Astrocytes; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Division; Cell Lineage; Cell Separation; Cells, Cultured; Female; Green Fluorescent Proteins; Hippocampus; Luminescent Proteins; Neurons; Oligodendroglia; Oxidopamine; Parkinsonian Disorders; Phenotype; Rats; Rats, Inbred F344; Stem Cell Transplantation; Stem Cells; Substantia Nigra | 2002 |
Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta.
Topics: Animals; Apoptosis; Biomarkers; Bromodeoxyuridine; CDC2 Protein Kinase; Cell Count; Cell Cycle Proteins; Cell Differentiation; Disease Models, Animal; Dopamine; G2 Phase; Mitosis; Neurons; Oxidopamine; Parkinsonian Disorders; Phosphoproteins; Rats; S Phase; Substantia Nigra | 2003 |
No evidence for new dopaminergic neurons in the adult mammalian substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromodeoxyuridine; Cell Movement; Dopamine; Male; Mice; Mice, Inbred C57BL; Neurons; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Stem Cells; Substantia Nigra; Tyrosine 3-Monooxygenase | 2004 |
Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons.
Topics: Animals; Behavior, Animal; beta Catenin; Bromodeoxyuridine; Cell Movement; Cell Proliferation; Corpus Striatum; Cytoskeletal Proteins; Disease Models, Animal; Dopamine; Drug Administration Routes; Intermediate Filament Proteins; Lateral Ventricles; Male; Nerve Tissue Proteins; Nestin; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Stem Cells; Trans-Activators; Transforming Growth Factor alpha; Tyrosine 3-Monooxygenase | 2004 |
Proliferation of neural precursors in the subventricular zone after chemical lesions of the nigrostriatal pathway in rat brain.
Topics: Animals; Biomarkers; Bromodeoxyuridine; Cell Movement; Cell Proliferation; Corpus Striatum; Denervation; Disease Models, Animal; Glial Fibrillary Acidic Protein; Male; Nerve Degeneration; Nerve Regeneration; Neural Cell Adhesion Molecule L1; Neural Pathways; Neuronal Plasticity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Recovery of Function; Sialic Acids; Stem Cells; Substantia Nigra; Tyrosine 3-Monooxygenase; Up-Regulation | 2006 |
Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.
Topics: Animals; Antibodies, Monoclonal; Antigens; Basal Ganglia; Biomarkers; Blood-Brain Barrier; Bromodeoxyuridine; Cell Count; Cell Proliferation; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Endothelial Cells; Female; Intermediate Filament Proteins; Levodopa; Motor Activity; Neovascularization, Pathologic; Nerve Tissue Proteins; Nestin; Oxidopamine; Parkinsonian Disorders; Platelet Endothelial Cell Adhesion Molecule-1; Proteoglycans; Rats; Rats, Sprague-Dawley | 2006 |
The isolation of neural stem cells from the olfactory bulb of Parkinson's disease model.
Topics: Animals; Bromodeoxyuridine; Cell Culture Techniques; Cell Differentiation; Cell Proliferation; Cell Separation; Cells, Cultured; Disease Models, Animal; Dopamine; Genetic Therapy; Genetic Vectors; Mice; Mice, Inbred C57BL; Neurons; Olfactory Bulb; Parkinsonian Disorders; Retroviridae; Spheroids, Cellular; Stem Cell Transplantation; Stem Cells; Tyrosine 3-Monooxygenase | 2007 |
Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromodeoxyuridine; Cell Differentiation; Coculture Techniques; Disease Models, Animal; Dopamine; Female; Functional Laterality; Gene Expression Regulation; Intercellular Signaling Peptides and Proteins; Motor Activity; Nerve Tissue Proteins; Neurons; Organ Culture Techniques; Oxidopamine; Paraganglia, Chromaffin; Parkinsonian Disorders; Protein Binding; Rats; Rats, Wistar; Receptors, Dopamine D2; Stem Cell Transplantation | 2008 |
Striatal carotid body graft promotes differentiation of neural progenitor cells into neurons in the olfactory bulb of adult hemiparkisonian rats.
Topics: Animals; Bromodeoxyuridine; Carotid Body; Cell Differentiation; Cell Movement; Corpus Striatum; Graft Survival; Male; Nerve Growth Factors; Neurons; Olfactory Bulb; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Stem Cells; Tyrosine 3-Monooxygenase | 2008 |
Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Bromodeoxyuridine; Cell Count; Cells, Cultured; Dopamine; Graft Survival; Immunohistochemistry; Male; Mesoderm; Mice; Mice, Inbred C57BL; Neostriatum; Parkinsonian Disorders; Recovery of Function; Stem Cell Transplantation; Stem Cells; Stromal Cells; Treatment Outcome; Tyrosine 3-Monooxygenase | 2001 |